Skip to main content

Advertisement

Table 1 Patients and tumors’ characteristics from the PePiTA trial and CTC sub-study

From: CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

  All patients Patients in CTC substudy
Variable
 Sample size No. 53 36
Age No. years
 Median 67 67
 Range 43–81 43–81
Gender No. (%)
 Male 32 (60) 25 (69)
 Female 21 (40) 11 (31)
Stage
 I/II 9 (17) / 13 (25) 4 (11)/9 (25)
 III/IV 27 (51) / 4 (8) 20 (56)/ 3(8)
Tumor Size No. (%)
 T1 1 (2) 1 (3)
 T2 11 (21) 5 (14)
 T3-T4 41 (77) 30 (83)
Lymph node status No. (%)
Negative 22 (42) 13 (36)
Positive 31 (58) 23 (64)